Free Trial

Target Healthcare REIT (THRL) Competitors

Target Healthcare REIT logo
GBX 103.20 0.00 (0.00%)
As of 06/13/2025 12:39 PM Eastern

THRL vs. AGR, PHP, IHR, LABS, MXF, DLN, IWG, BYG, GPOR, and SRE

Should you be buying Target Healthcare REIT stock or one of its competitors? The main competitors of Target Healthcare REIT include Assura (AGR), Primary Health Properties (PHP), Impact Healthcare REIT (IHR), Life Science REIT (LABS), Medicx Fund (MXF), Derwent London (DLN), IWG (IWG), Big Yellow Group (BYG), Great Portland Estates (GPOR), and Sirius Real Estate (SRE). These companies are all part of the "real estate" sector.

Target Healthcare REIT vs. Its Competitors

Assura (LON:AGR) and Target Healthcare REIT (LON:THRL) are both small-cap real estate companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership, profitability and earnings.

73.7% of Assura shares are owned by institutional investors. Comparatively, 69.4% of Target Healthcare REIT shares are owned by institutional investors. 8.4% of Assura shares are owned by insiders. Comparatively, 0.1% of Target Healthcare REIT shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Assura has a beta of 0.37, meaning that its share price is 63% less volatile than the S&P 500. Comparatively, Target Healthcare REIT has a beta of 0.44, meaning that its share price is 56% less volatile than the S&P 500.

Assura currently has a consensus target price of GBX 51, suggesting a potential upside of 1.85%. Given Assura's stronger consensus rating and higher possible upside, research analysts plainly believe Assura is more favorable than Target Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Assura
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Target Healthcare REIT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Assura received 278 more outperform votes than Target Healthcare REIT when rated by MarketBeat users. Likewise, 67.21% of users gave Assura an outperform vote while only 65.03% of users gave Target Healthcare REIT an outperform vote.

CompanyUnderperformOutperform
AssuraOutperform Votes
371
67.21%
Underperform Votes
181
32.79%
Target Healthcare REITOutperform Votes
93
65.03%
Underperform Votes
50
34.97%

Assura pays an annual dividend of GBX 3 per share and has a dividend yield of 6.0%. Target Healthcare REIT pays an annual dividend of GBX 6 per share and has a dividend yield of 5.8%. Assura pays out -286.8% of its earnings in the form of a dividend. Target Healthcare REIT pays out 50.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Assura is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Target Healthcare REIT had 3 more articles in the media than Assura. MarketBeat recorded 3 mentions for Target Healthcare REIT and 0 mentions for Assura. Assura's average media sentiment score of 1.38 beat Target Healthcare REIT's score of 0.37 indicating that Assura is being referred to more favorably in the media.

Company Overall Sentiment
Assura Positive
Target Healthcare REIT Neutral

Target Healthcare REIT has a net margin of 104.99% compared to Assura's net margin of -18.09%. Target Healthcare REIT's return on equity of 10.78% beat Assura's return on equity.

Company Net Margins Return on Equity Return on Assets
Assura-18.09% -1.92% 2.82%
Target Healthcare REIT 104.99%10.78%3.86%

Target Healthcare REIT has lower revenue, but higher earnings than Assura. Assura is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Assura£188.76M8.64-£34.15M-£1.05-47.87
Target Healthcare REIT£68.64M9.20£72.07M£11.938.65

Summary

Assura beats Target Healthcare REIT on 11 of the 20 factors compared between the two stocks.

Get Target Healthcare REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for THRL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding THRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THRL vs. The Competition

MetricTarget Healthcare REITREIT IndustryReal Estate SectorLON Exchange
Market Cap£631.69M£1.65B£1.59B£2.91B
Dividend Yield7.00%7.52%6.32%4.90%
P/E Ratio8.651.4410.27124.60
Price / Sales9.20548.001,640.36248,064.90
Price / Cash14.3749.2266.7928.07
Price / Book0.931.441.284.64
Net Income£72.07M-£74.43M-£120.13M£5.91B
7 Day Performance1.38%0.75%0.52%12.86%
1 Month Performance4.24%2.31%2.83%25.97%
1 Year Performance29.81%16.41%8.99%77.96%

Target Healthcare REIT Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THRL
Target Healthcare REIT
N/AGBX 103.20
flat
N/A+29.8%£631.69M£68.64M8.65N/ANews Coverage
High Trading Volume
AGR
Assura
1.4134 of 5 stars
GBX 49.36
-0.1%
GBX 51
+3.3%
+26.8%£1.61B£188.76M-47.1884
PHP
Primary Health Properties
1.0682 of 5 stars
GBX 99
-0.1%
GBX 107.50
+8.6%
+12.8%£1.33B£178.59M-154.5458News Coverage
IHR
Impact Healthcare REIT
N/AN/AGBX 114
+∞
N/A£361.75M£53.51M793.64N/A
LABS
Life Science REIT
N/AGBX 41.80
flat
GBX 46.50
+11.2%
+18.1%£148.40M£20.41M-3.71N/A
MXF
Medicx Fund
N/AN/AN/AN/A£0.00N/A0.00N/AHigh Trading Volume
DLN
Derwent London
2.6525 of 5 stars
GBX 1,950
+0.4%
GBX 2,700
+38.5%
-14.7%£2.18B£277.67M-6.05199Gap Down
IWG
IWG
N/AGBX 204.80
+2.6%
N/A+11.1%£2.06B£2.76B-15.2310,000Gap Up
BYG
Big Yellow Group
N/AGBX 985
+0.7%
N/A-15.7%£1.92B£200.54M7.98503News Coverage
Positive News
Dividend Announcement
GPOR
Great Portland Estates
N/AN/AN/AN/A£1.87B£100.70M124.66210Gap Up
SRE
Sirius Real Estate
3.8762 of 5 stars
GBX 97
-0.3%
GBX 117.50
+21.1%
-5.0%£1.75B£386.21M12.69241Positive News
Gap Up

Related Companies and Tools


This page (LON:THRL) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners